ARCHIVES

CCOP Controversy Goes On: DCT Board Objects, Says It Was Left Out; Moorhead, DeVita Clarify Positions

This article is from The Cancer Letter archive.

Vol. 08 No. 08 | February 19, 1982

Download PDF Visit The Full Archive

Related Articles

NEJM Does About-Face, Issues Correction On CT Lung Cancer Screening Study.

April 4, 2008

Tough Year Seen for Cooperative Groups; Priority Payment Questioned

December 2, 1988

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991

Amgen’s Kepivance Approved For Severe Oral Mucositis

January 28, 2005

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Harkin, Specter Propose A $5.2-Billion Supplement For NIH. Senate Report Says NIH Funding At “Crisis Point.”

July 18, 2008